Trademark: 85817229
Status Date
Thursday, January 8, 2015
Filing Date
Monday, January 7, 2013
Abandoned Date
Monday, December 15, 2014
1 Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; Molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes for scientific and research purposes; Biological and chemical reagents, namely, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use
5 Protein cell lysates, genornic DNA preparations and formalin fixed, paraffin embedded (FFPE) engineered tumor tissue mimics for medical diagnostic use
42 Custom cell-line engineering services; Scientific research in the field of genetics and genetic engineering, namely, gene-editing services, DNA modeling services, gene engineering services, establishing patient genotypes; Bio-technology, pharmaceutical and scientific testing, research and development services relating to genetics, and providing advice, consultancy and information services related thereto; biological research; pharmaceutical research services; drug discovery services; Scientific research and development services for lead identification and validation; Scientific research and development services for target identification and validation; Pharmaceutical research, namely, identification of patient-relevant drug targets, optimization of drug candidates for clinical development; Laboratory diagnostic services, namely, diagnosis of genetic mutations for clinical or research purposes and the design of molecular reference standards for assay development, clinical diagnostic quality control and proficiency schemes for the medical diagnostic services industry; medicinal research services, namely, hit discovery and hit to lead services; research and development services in the nature of creating libraries and collections of cells and cell lines, chemicals and compounds; research and development services in the nature of creating libraries and collections of normal and mutated genes; Scientific research and development services relating to targeting therapies to individuals; Scientific research and development services relating to combining therapies for individuals; research and development relating to reagents; Scientific research in the field of disease modeling; Medical and scientific research, namely, designing and conducting clinical trials for others; research and development in re-positioning existing drugs from other therapeutic indications
Color is not claimed as a feature of the mark.
SYNTHETIC
Jan 8, 2015
Abandonment Notice Mailed - Failure To Respond
Jan 8, 2015
Abandonment - Failure To Respond Or Late Response
Jun 12, 2014
Non-Final Action Mailed
Jun 11, 2014
Non-Final Action Written
Jun 11, 2014
Previous Allowance Count Withdrawn
May 18, 2014
Withdrawn From Pub - Og Review Query
May 2, 2014
Law Office Publication Review Completed
May 1, 2014
Examiners Amendment Mailed
Apr 30, 2014
Approved For Pub - Principal Register
Apr 30, 2014
Examiner's Amendment Entered
Apr 30, 2014
Examiners Amendment -Written
Apr 25, 2014
Amendment From Applicant Entered
Apr 25, 2014
Correspondence Received In Law Office
Apr 15, 2014
Paper Received
Nov 4, 2013
Non-Final Action Mailed
Nov 1, 2013
Non-Final Action Written
Oct 17, 2013
Amendment From Applicant Entered
Oct 17, 2013
Correspondence Received In Law Office
Oct 10, 2013
Paper Received
Apr 11, 2013
Non-Final Action Mailed
Apr 10, 2013
Non-Final Action Written
Apr 8, 2013
Assigned To Examiner
Feb 21, 2013
Amendment From Applicant Entered
Feb 21, 2013
Correspondence Received In Law Office
Feb 13, 2013
Assigned To Lie
Feb 8, 2013
Paper Received
Jan 17, 2013
Notice Of Pseudo Mark Mailed
Jan 16, 2013
New Application Office Supplied Data Entered In Tram
Jan 10, 2013
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
